[PRESSWIRE] Germany - 21 December, 2020 -- N-PATH is the most innovative European training course in interventional nephrology funded by European Commission in the framework of the Erasmus+ program coordinated by the University of Bari, in collaboration with the European Renal Association (ERA-EDTA), the Vascular Access Society, important international academic centers and two companies specialized in medical training.

[PRESSWIRE] Austria - 19.11.20 -- Eveliqure Biotechnologies GmbH, a clinical-stage biotechnology company, today announces the publication of preclinical data with ShigETEC, its vaccine candidate against Shigellae and Enterotoxic E. coli in the peer-reviewed journal Vaccines (https://doi.org/10.3390/vaccines8040689).

[PRESSWIRE] UK - 18.11.20 -- Hundreds of religious leaders from around the world gather to pray for the end of COVID-19 ahead of a group plasma donation by 4,000 Shincheonji members...

New policy framework for digital governance calls for fundamental re-set of data regulation across telecoms and technology industries.

[PRESSWIRE] London, UK - 21 October, 2020 -- The new series of e-seminars is designed to give participants a compre­hensive update on current issues and to encourage vibrant discussions. The underlying idea is to bridge the gap between research and practice by communicating and analyzing the findings from recent studies and thus to implement them in clinical practice. Another set of e-seminars will focus on the current state of the art in diagnosing and treating the various nephrological indications, which will be particularly interesting for young doctors and/or PA students.

[PRESSWIRE] CA, US - 18 September, 2020 -- Airionex announced today the results of new independent testing. Varionix® active bipolar ionization air cleaning technology from Airionex has been verified to be effective for disinfecting coronavirus from the air. The virus was completely eliminated within minutes.

Anthemis and IA Capital Group Participate in Round; Nephila Capital and Munich Re to Provide Risk Capacity...

[PRESSWIRE] Vienna - 30th June 2020 -- Eveliqure Biotechnologies today announces that further financing has been secured from Arax Capital Partners comprising the last instalment of a €1.7M total investment provided by Arax. This is complemented by further private investment from Baobá and a Swiss based family office, and totals around €0.5M.

[PRESSWIRE] Vienna - 4 June, 2020 -- The Austrian biotech company CEBINA GmbH announces that it has received seed funding for its extended spectrum Coronavirus vaccine project, which is part of CEBINA’s broad-scale efforts offering short-, mid- and longer-term solutions to fight the COVID-19 pandemic. This seed funding will support proof-of-concept studies of the vaccine that will allow progress to pre-clinical development, scheduled for Q1/2021. The funds are provided by the Blom Family Office.

[PRESSWIRE] Brussels - 2 June, 2020 -- The EBRAINS shared Research Infrastructure for brain research is pleased to announce a significant step forward with the appointment of its founding CEO Paweł Świeboda. The EBRAINS digital brain research infrastructure is a key outcome of the European Commission’s Flagship 10-year research initiative Human Brain Project.